Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 1;145(7):1774-1781.
doi: 10.1002/ijc.32365. Epub 2019 May 6.

Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk

Sander de Kort  1   2   3 , Colinda C J M Simons  1 , Piet A van den Brandt  1 , Maryska L G Janssen-Heijnen  1   4 , Silvia Sanduleanu  2   3 , Ad A M Masclee  2   3 , Matty P Weijenberg  1
Affiliations

Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk

Sander de Kort et al. Int J Cancer. .

Abstract

Genetic variation in the insulin-like growth factor (IGF) pathway may further increase the risk of colorectal cancer (CRC) associated with type 2 diabetes mellitus (T2DM). Joint effects of T2DM and genetic variation in the IGF pathway on CRC risk can increase mechanistic insights. Participants from the Netherlands Cohort Study (n = 120, 852) completed a baseline questionnaire in 1986 when 55-69 years old (case-cohort, nsubcohort = 5,000, ncases = 3,441 after 16.3 years follow-up). Self-reported DM at baseline with onset at ≥30 years was classified as T2DM. Eighteen single nucleotide polymorphisms (SNPs) from the IGF pathway were aggregated in a genetic risk score (GRS). Cox proportional hazard ratios (HRs) for CRC were estimated according to combinations of T2DM status with GRS tertiles and categories of an IGF1 19-CA repeat polymorphism. Baseline T2DM prevalence was 3.1% in subcohort members and 3.8% in CRC cases. Comparison of combined categories with non-T2DM individuals in the lowest GRS tertile as reference showed that those in the highest GRS tertiles with and without T2DM had significantly increased CRC risks, particularly those with T2DM (HR = 2.28, 95% CI: 1.11, 4.66). As compared to IGF1 19-CA wild-type carriers without T2DM, carrying two IGF1 19-CA variant repeat alleles were associated with a significantly decreased CRC risk in those without T2DM (HR = 0.76, 95% CI: 0.63-0.91). This association was absent when T2DM was present. Our study of joint effects indicated that the presence of unfavorable alleles in the IGF pathway may further increase the risk of CRC associated with T2DM.

Keywords: cohort studies; colorectal cancer; diabetes mellitus; gene-environment interactions; insulin-like growth factors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. GLOBOCAN Cancer Fact Sheets: Colorectal Cancer Available from: http://globocan.iarc.fr/factsheet.asp [date last accessed March 27, 2013].
    1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country‐years and 2·7 million participants. Lancet 2011;378:31–40. - PubMed
    1. Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of meta‐analyses of observational studies. BMJ 2015;350:g7607. - PubMed
    1. Giovannucci E. Insulin, insulin‐like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S–20S. - PubMed
    1. Simons CCJM, Schouten LJ, Godschalk RWL, et al. Genetic variants in the insulin‐like growth factor pathway and colorectal cancer risk in The Netherlands cohort study. Sci Rep 2015;5:14126. - PMC - PubMed

Publication types

Substances